Back to search
FDAFDA · Food and drugs·Recall number D-1099-2023

Unguentine Ointment, (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Zinc Oxide 6.6%), labeled as a) NET WT 1 OZ (28 g) tubes, Improved Formula, UPC 0 11169 10216 0, and b) NET WT 1 OZ (28.3g) tubes, Maximum Strength, UPC 0 11169 11250 3, Distributed by: Oakhurst Company, Levittown, NY 11756.

Published August 30, 2023 · Recall initiated: August 9, 2023

Summary

FDA records drug Class II recall D-1099-2023, published August 30, 2023 and initiated August 9, 2023. Recalling firm: Ecometics, Inc.; Status: Completed; Reported quantity: a) 6,120 tubes, b) 540 tubes; Lot: a) and b) 1E113A, exp 4/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Products not manufactured under current good manufacturing practices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ecometics, Inc.
Distributor
Nationwide in the USA
Lot
a) and b) 1E113A, exp 4/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Unguentine Ointment, (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Zinc Oxide 6.6%), labeled as a) NET WT 1 OZ (28 g) tubes, Improved Formula, UPC 0 11169 10216 0, and b) NET WT 1 OZ (28.3g) tubes, Maximum Strength, UPC 0 11169 11250 3, Distributed by: Oakhurst Company, Levittown, NY 11756. recalled?

Yes. FDA published recall D-1099-2023 on August 30, 2023. Reported hazard: CGMP Deviations: Products not manufactured under current good manufacturing practices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter